Published in Ann Surg on June 01, 1974
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunological enhancement as studied by cell culture techniques. Annu Rev Microbiol (1970) 3.12
Quantitation of peripheral blood lymphocyte cultures. Nature (1966) 2.19
Cardiac transplantation in man. 3. Surgical aspects. Am J Surg (1969) 1.72
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol (1971) 1.60
Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA). Transplant Proc (1969) 1.47
Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement. J Immunol (1972) 1.33
Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. J Natl Cancer Inst (1971) 1.17
Macrophage-like properties of some guinea-pig transformed cells. Int Arch Allergy Appl Immunol (1967) 1.13
Acute rejection of the allogrfted human heart. Ann Thorac Surg (1971) 1.09
Immunologically stimulated human peripheral blood lymphocytes in vitro. II. Mixed lymphocyte cultures with related and unrelated donors. Int Arch Allergy Appl Immunol (1966) 0.89
Recognition pathway in lymphocytes. J Theor Biol (1969) 0.88
Current clinical applications of lymphocyte tissue culture. Guys Hosp Rep (1971) 0.84
Inhibition of the response in mixed leukocyte cultures by alloimmune plasma. Transplantation (1970) 0.82
Results of 54 cardiac transplants. Surgery (1973) 0.81
Inhibition of the mixed leukocyte reaction as an assay for enhancing alloantiserum. Transplantation (1971) 0.79
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
Response of human blood lymphocytes to tuberculin PPD in tissue culture. Immunology (1967) 4.09
Management of acute aortic dissections. Ann Thorac Surg (1970) 3.66
Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg (1999) 2.90
Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 2.87
Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg (1975) 2.43
The cardiac donor. Surg Gynecol Obstet (1971) 2.39
Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Quantitation of peripheral blood lymphocyte cultures. Nature (1966) 2.19
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation (1992) 2.04
Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis (1981) 2.03
Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01
Temporary neurological dysfunction after deep hypothermic circulatory arrest: a clinical marker of long-term functional deficit. Ann Thorac Surg (1999) 1.98
Neuropsychologic outcome after deep hypothermic circulatory arrest in adults. J Thorac Cardiovasc Surg (1999) 1.94
Neurologic outcome after ascending aorta-aortic arch operations: effect of brain protection technique in high-risk patients. J Thorac Cardiovasc Surg (2001) 1.93
Multiple valve replacement with the fresh aortic homograft. J Thorac Cardiovasc Surg (1968) 1.90
Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg (1990) 1.88
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82
Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2 picrylhydrazyl radical. Biochem Pharmacol (1998) 1.81
Cardiac transplantation in man. 3. Surgical aspects. Am J Surg (1969) 1.72
The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci U S A (2006) 1.71
Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation (1979) 1.70
Transcatheter coil occlusion of surgical fenestration after Fontan operation. Circulation (1996) 1.68
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Ebstein's anomaly appearing in the neonate. A new surgical approach. J Thorac Cardiovasc Surg (1991) 1.62
Primary cardiac neoplasms. Early and late results of surgical treatment in 42 patients. J Thorac Cardiovasc Surg (1987) 1.60
Operative treatment of aortic dissections. Experience with 125 patients over a sixteen-year period. J Thorac Cardiovasc Surg (1979) 1.57
Left-to-right shunts in control of bleeding following surgery for aneurysms of the ascending aorta. Chest (1987) 1.55
A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med (1993) 1.54
Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant (1996) 1.54
Hypothermic circulatory arrest in operations on the thoracic aorta. Determinants of operative mortality and neurologic outcome. J Thorac Cardiovasc Surg (1994) 1.52
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation (1999) 1.52
Valve replacement in active bacterial endocarditis. N Engl J Med (1967) 1.50
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv (2002) 1.49
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49
Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg (1973) 1.49
Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol (1990) 1.49
Hemodynamic performance of the transplanted human heart. Surgery (1971) 1.47
Involvement of apoptosis in neurological injury after hypothermic circulatory arrest: a new target for therapeutic intervention? Ann Thorac Surg (2001) 1.47
Heart and lung transplantation: autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg (1980) 1.47
Long-term experience with porcine aortic valve xenografts. J Thorac Cardiovasc Surg (1977) 1.47
Surgical management of aortic dissection during a 30-year period. Circulation (1995) 1.46
Aortic dissection involving a double aortic arch with a right descending aorta. Ann Thorac Surg (1994) 1.46
Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg (1977) 1.45
Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med (1983) 1.45
Radical replacement of the aortic root in acute type A dissection: indications and outcome. Eur J Cardiothorac Surg (1996) 1.45
Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol (1972) 1.45
Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44
Twenty-eight cases of human heart-lung transplantation. Lancet (1986) 1.44
Hemodynamic observations one and two years after cardiac transplantation in man. Circulation (1972) 1.42
Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol (1991) 1.42
Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology (2010) 1.41
Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. Eur Heart J (1997) 1.41
Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med (1971) 1.40
Coronary arterial narrowing in Takayasu's aortitis. Am J Cardiol (1977) 1.40
Infectious complications in heart-lung transplant recipients. Am J Med (1985) 1.40
Retrograde cerebral perfusion during thoracic aortic surgery and late neuropsychological dysfunction. Eur J Cardiothorac Surg (2001) 1.40
Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers. Circulation (1975) 1.40
About viability in valve grafts. Ann Thorac Surg (1989) 1.39